Literature DB >> 23570729

Use of sodium bicarbonate to promote weight gain, maintain body temperature, normalize renal functions and minimize mortality in rodents receiving the chemotherapeutic agent cisplatin.

Josée Guindon1, Andrea G Hohmann.   

Abstract

A simple method to reduce adverse effects of the chemotherapeutic agent cisplatin on animal health is described. Animals receiving normal saline (0.9% NaCl) s.c. prior to once weekly injections of cisplatin (3 mg/kg i.p.×3 or 4 weeks) exhibited failure of weight gain, lowered body temperature, elevations in creatinine and ketone levels and increased kidney weight ratios. By contrast, rats treated with sodium bicarbonate (4% NaHCO3 in saline s.c.) prior to cisplatin (3 mg/kg i.p.×3 or 4 weeks) exhibited normal weight gain, body temperature, creatinine and ketone levels, as well as normal kidney weight ratios (over 16 or 28 days, respectively). Cisplatin-induced neuropathy (i.e. mechanical and cold allodynia) developed equivalently in both groups. Our studies suggest that NaHCO3 pretreatment promotes animal health and minimizes weight loss, body temperature dysregulation and signs of renal toxicity (i.e. increases in creatinine and kidney weight ratio) following repeated cisplatin treatment without altering the development of chemotherapy-induced peripheral neuropathy.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570729      PMCID: PMC3682661          DOI: 10.1016/j.neulet.2013.03.033

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  27 in total

Review 1.  An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity.

Authors:  Penélope D Sánchez-González; Francisco J López-Hernández; José M López-Novoa; Ana I Morales
Journal:  Crit Rev Toxicol       Date:  2011-08-12       Impact factor: 5.635

2.  WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat.

Authors:  Gema Vera; Anna Chiarlone; Pablo Antonio Cabezos; David Pascual; María Isabel Martín; Raquel Abalo
Journal:  Life Sci       Date:  2007-06-28       Impact factor: 5.037

3.  Altered feeding behaviour induced by long-term cisplatin in rats.

Authors:  Gema Vera; Anna Chiarlone; Ma Isabel Martín; Raquel Abalo
Journal:  Auton Neurosci       Date:  2006-03-29       Impact factor: 3.145

Review 4.  Manipulating tumor acidification as a cancer treatment strategy.

Authors:  Mark F McCarty; Julian Whitaker
Journal:  Altern Med Rev       Date:  2010-09

5.  Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.

Authors:  Olivier Mir; Stanislas Ropert; Antoine Babinet; Jérôme Alexandre; Frédérique Larousserie; Jean-Philippe Durand; Eric Enkaoua; Philippe Anract; François Goldwasser
Journal:  Cancer Chemother Pharmacol       Date:  2010-02-13       Impact factor: 3.333

6.  Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay.

Authors:  A Keppler; N Gretz; R Schmidt; H-M Kloetzer; H-J Groene; B Lelongt; M Meyer; M Sadick; J Pill
Journal:  Kidney Int       Date:  2006-11-01       Impact factor: 10.612

7.  The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion.

Authors:  Ariosto S Silva; Jose A Yunes; Robert J Gillies; Robert A Gatenby
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 8.  Animal models of chemotherapy-evoked painful peripheral neuropathies.

Authors:  Nicolas Authier; David Balayssac; Fabien Marchand; Bing Ling; Aude Zangarelli; Juliette Descoeur; François Coudore; Emmanuel Bourinet; Alain Eschalier
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

9.  Resveratrol attenuates cisplatin-induced nephrotoxicity in rats.

Authors:  Cátia Lira Do Amaral; Heloísa Della Coletta Francescato; Terezila Machado Coimbra; Roberto Silva Costa; Joana D'arc Castania Darin; Lusânia Maria Greggi Antunes; Maria De Lourdes Pires Bianchi
Journal:  Arch Toxicol       Date:  2007-11-20       Impact factor: 5.153

Review 10.  Cisplatin nephrotoxicity: a review.

Authors:  Xin Yao; Kessarin Panichpisal; Neil Kurtzman; Kenneth Nugent
Journal:  Am J Med Sci       Date:  2007-08       Impact factor: 2.378

View more
  10 in total

Review 1.  Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.

Authors:  Henry L Blanton; Jennifer Brelsfoard; Nathan DeTurk; Kevin Pruitt; Madhusudhanan Narasimhan; Daniel J Morgan; Josée Guindon
Journal:  Drugs       Date:  2019-06       Impact factor: 9.546

2.  Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin.

Authors:  Hanan Abumanhal-Masarweh; Lilach Koren; Assaf Zinger; Zvi Yaari; Nitzan Krinsky; Galoz Kaneti; Nitsan Dahan; Yael Lupu-Haber; Edith Suss-Toby; Esther Weiss-Messer; Michal Schlesinger-Laufer; Janna Shainsky-Roitman; Avi Schroeder
Journal:  J Control Release       Date:  2019-01-05       Impact factor: 9.776

3.  Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status.

Authors:  Josée Guindon; Liting Deng; Baochang Fan; Jim Wager-Miller; Andrea G Hohmann
Journal:  Mol Pain       Date:  2014-09-04       Impact factor: 3.395

4.  Paclitaxel-induced hypothermia and hypoperfusion increase breast cancer metastasis and angiogenesis in mice.

Authors:  Nozomi Ami; Hideki Sato; Yoshihiro Hayakawa
Journal:  Oncol Lett       Date:  2017-12-14       Impact factor: 2.967

5.  Gastric myoelectric activity during cisplatin-induced acute and delayed emesis reveals a temporal impairment of slow waves in ferrets: effects not reversed by the GLP-1 receptor antagonist, exendin (9-39).

Authors:  Zengbing Lu; Man P Ngan; Ge Lin; David T W Yew; Xiaodan Fan; Paul L R Andrews; John A Rudd
Journal:  Oncotarget       Date:  2017-10-16

6.  Protective Effect of D-Methionine on Body Weight Loss, Anorexia, and Nephrotoxicity in Cisplatin-Induced Chronic Toxicity in Rats.

Authors:  Ming-Tai Lin; Jiunn-Liang Ko; Te-Chung Liu; Pei-Tsen Chao; Chu-Chyn Ou
Journal:  Integr Cancer Ther       Date:  2018-02-11       Impact factor: 3.279

7.  D-Methionine Ameliorates Cisplatin-Induced Muscle Atrophy via Inhibition of Muscle Degradation Pathway.

Authors:  Ching-Te Wu; Jiuan-Miaw Liao; Jiunn-Liang Ko; Yao-Ling Lee; Hui-Yi Chang; Cheng-Hsi Wu; Chu-Chyn Ou
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

8.  Insights Into Acute and Delayed Cisplatin-Induced Emesis From a Microelectrode Array, Radiotelemetry and Whole-Body Plethysmography Study of Suncus murinus (House Musk Shrew).

Authors:  Longlong Tu; Julia Y H Liu; Zengbing Lu; Dexuan Cui; Man P Ngan; Peng Du; John A Rudd
Journal:  Front Pharmacol       Date:  2021-12-03       Impact factor: 5.810

9.  Preclinical activity of melflufen (J1) in ovarian cancer.

Authors:  Charlotte Carlier; Sara Strese; Kristina Viktorsson; Ebba Velander; Peter Nygren; Maria Uustalu; Therese Juntti; Rolf Lewensohn; Rolf Larsson; Jack Spira; Elly De Vlieghere; Wim P Ceelen; Joachim Gullbo
Journal:  Oncotarget       Date:  2016-09-13

10.  Changes in hemodynamics, renal blood flow and urine output during continuous renal replacement therapies.

Authors:  S N Fernández; M J Santiago; R González; J López; M J Solana; J Urbano; J López-Herce
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.